Global Fertility Services Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Fertility Services Market Research Report 2024
Fertility is the natural capability to produce offspring. As a measure, fertility rate is the number of offspring born per mating pair, individual or population. Fertility differs from fecundity, which is defined as the potential for reproduction (influenced by gamete production, fertilization and carrying a pregnancy to term). A lack of fertility is infertility while a lack of fecundity would be called sterility.
According to MRAResearch’s new survey, global Fertility Services market is projected to reach US$ 19030 million in 2033, increasing from US$ 11410 million in 2022, with the CAGR of 7.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fertility Services market research.
The underlying causes covered in the fertility services market report include male and female infertility. Among the two, female infertility is likely to be the dominant segment over the forecast period. Factors credited to the success of the segment include the prevalence of obesity, elapsed age of motherhood, endometrial tuberculosis, and other medical conditions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Fertility Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Merck (Germany)
Cook Medical (U.S.)
Irvine Scientific (U.S.)
CooperSurgical (U.S.)
CARE Fertility Group (U.K.)
Ferring Pharmaceuticals (U.S.)
Vitrolife (U.S.)
Monash IVF Group (Australia)
Segment by Type
Infertility Drugs
Assisted Reproductive Technology (ART)
Male
Female
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Fertility Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Fertility Services market is projected to reach US$ 19030 million in 2033, increasing from US$ 11410 million in 2022, with the CAGR of 7.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fertility Services market research.
The underlying causes covered in the fertility services market report include male and female infertility. Among the two, female infertility is likely to be the dominant segment over the forecast period. Factors credited to the success of the segment include the prevalence of obesity, elapsed age of motherhood, endometrial tuberculosis, and other medical conditions.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Fertility Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck (Germany)
Cook Medical (U.S.)
Irvine Scientific (U.S.)
CooperSurgical (U.S.)
CARE Fertility Group (U.K.)
Ferring Pharmaceuticals (U.S.)
Vitrolife (U.S.)
Monash IVF Group (Australia)
Segment by Type
Infertility Drugs
Assisted Reproductive Technology (ART)
Segment by Application
Male
Female
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Fertility Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source